![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/407 | (2006.01) | ||
C07D 519/00 | (2006.01) | ||
A61P 7/00 | (2006.01) |
(11) | Number of the document | 3448859 |
(13) | Kind of document | T |
(96) | European patent application number | 18716455.3 |
Date of filing the European patent application | 2018-03-20 | |
(97) | Date of publication of the European application | 2019-03-06 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
(46) | Date of publication of the claims translation | 2019-10-25 |
(86) | Number | PCT/US2018/023405 |
Date | 2018-03-20 |
(87) | Number | WO 2018/175474 |
Date | 2018-09-27 |
(30) | Number | Date | Country code |
201762473751 P | 2017-03-20 | US |
(72) |
ERICSSON, Anna, US
GREEN, Neal, US
GUSTAFSON, Gary, US
HAN, Bingsong, US
LANCIA, JR., David R., US
MITCHELL, Lorna, US
RICHARD, David, US
SHELEKHIN, Tatiana, US
SMITH, Chase C., US
WANG, Zhongguo, US
ZHENG, Xiaozhang, US
|
(73) |
Novo Nordisk Health Care AG,
The Circle 32/38, 8058 Zürich,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirolpirolo kompozicijos, kaip piruvato kinazės (PKR) aktyvatoriai |
PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS |
Payment date | Validity (years) | Amount | |
2025-02-18 | 8 | 185.00 EUR |
2026-03-20 |